MX2022015333A - Medicamento de combinacion para el control y manejo de la diabetes mellitus tipo 2. - Google Patents

Medicamento de combinacion para el control y manejo de la diabetes mellitus tipo 2.

Info

Publication number
MX2022015333A
MX2022015333A MX2022015333A MX2022015333A MX2022015333A MX 2022015333 A MX2022015333 A MX 2022015333A MX 2022015333 A MX2022015333 A MX 2022015333A MX 2022015333 A MX2022015333 A MX 2022015333A MX 2022015333 A MX2022015333 A MX 2022015333A
Authority
MX
Mexico
Prior art keywords
type
control
diabetes mellitus
management
combination drug
Prior art date
Application number
MX2022015333A
Other languages
English (en)
Inventor
León Sixto Serafín Espinoza
Rubio Paola Yazmín Ollervides
Canudas Jorge Alejandro González
Escobar Ernesto Cuahutencos
Original Assignee
Laboratorios Silanes S A De C V
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Application filed by Laboratorios Silanes S A De C V filed Critical Laboratorios Silanes S A De C V
Publication of MX2022015333A publication Critical patent/MX2022015333A/es

Links

Classifications

    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K31/00—Medicinal preparations containing organic active ingredients
    • A61K31/64—Sulfonylureas, e.g. glibenclamide, tolbutamide, chlorpropamide
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P3/00—Drugs for disorders of the metabolism
    • A61P3/08—Drugs for disorders of the metabolism for glucose homeostasis
    • A61P3/10—Drugs for disorders of the metabolism for glucose homeostasis for hyperglycaemia, e.g. antidiabetics
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K31/00—Medicinal preparations containing organic active ingredients
    • A61K31/13—Amines
    • A61K31/155—Amidines (), e.g. guanidine (H2N—C(=NH)—NH2), isourea (N=C(OH)—NH2), isothiourea (—N=C(SH)—NH2)
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K31/00—Medicinal preparations containing organic active ingredients
    • A61K31/33—Heterocyclic compounds
    • A61K31/395—Heterocyclic compounds having nitrogen as a ring hetero atom, e.g. guanethidine or rifamycins
    • A61K31/40—Heterocyclic compounds having nitrogen as a ring hetero atom, e.g. guanethidine or rifamycins having five-membered rings with one nitrogen as the only ring hetero atom, e.g. sulpiride, succinimide, tolmetin, buflomedil
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K45/00—Medicinal preparations containing active ingredients not provided for in groups A61K31/00 - A61K41/00
    • A61K45/06—Mixtures of active ingredients without chemical characterisation, e.g. antiphlogistics and cardiaca
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K9/00—Medicinal preparations characterised by special physical form
    • A61K9/20—Pills, tablets, discs, rods
    • A61K9/2004—Excipients; Inactive ingredients
    • A61K9/2009—Inorganic compounds
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K9/00—Medicinal preparations characterised by special physical form
    • A61K9/20—Pills, tablets, discs, rods
    • A61K9/2004—Excipients; Inactive ingredients
    • A61K9/2013—Organic compounds, e.g. phospholipids, fats
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K9/00—Medicinal preparations characterised by special physical form
    • A61K9/20—Pills, tablets, discs, rods
    • A61K9/2004—Excipients; Inactive ingredients
    • A61K9/2022—Organic macromolecular compounds
    • A61K9/2027—Organic macromolecular compounds obtained by reactions only involving carbon-to-carbon unsaturated bonds, e.g. polyvinyl pyrrolidone, poly(meth)acrylates
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K9/00—Medicinal preparations characterised by special physical form
    • A61K9/20—Pills, tablets, discs, rods
    • A61K9/2004—Excipients; Inactive ingredients
    • A61K9/2022—Organic macromolecular compounds
    • A61K9/2031—Organic macromolecular compounds obtained otherwise than by reactions only involving carbon-to-carbon unsaturated bonds, e.g. polyethylene glycol, polyethylene oxide, poloxamers
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K9/00—Medicinal preparations characterised by special physical form
    • A61K9/20—Pills, tablets, discs, rods
    • A61K9/2004—Excipients; Inactive ingredients
    • A61K9/2022—Organic macromolecular compounds
    • A61K9/205—Polysaccharides, e.g. alginate, gums; Cyclodextrin
    • A61K9/2054—Cellulose; Cellulose derivatives, e.g. hydroxypropyl methylcellulose
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K2300/00—Mixtures or combinations of active ingredients, wherein at least one active ingredient is fully defined in groups A61K31/00 - A61K41/00
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K9/00—Medicinal preparations characterised by special physical form
    • A61K9/20—Pills, tablets, discs, rods

Abstract

La presente invención se relaciona a un medicamento innovador estable de liberación inmediata para el tratamiento, el control y un mejor manejo de la diabetes Mellitus tipo 2 conteniendo una sulfonilurea como por ejemplo glimepirida, un inhibidor de la dipeptidil peptidasa-4 (DPP4) como por ejemplo vildagliptina, y una biguanidina como por ejemplo metformina. A la vez, la presente invención permite solucionar un conjunto de importantes retos tecnológicos en la fabricación de dicho medicamento debido a las propiedades fisicoquímicas y a la diferencia en dosis de la combinación sinérgica de los fármacos.
MX2022015333A 2020-09-02 2020-09-02 Medicamento de combinacion para el control y manejo de la diabetes mellitus tipo 2. MX2022015333A (es)

Applications Claiming Priority (1)

Application Number Priority Date Filing Date Title
PCT/MX2020/050030 WO2022050832A1 (es) 2020-09-02 2020-09-02 Medicamento de combinación para el control y manejo de la diabetes mellitus tipo 2

Publications (1)

Publication Number Publication Date
MX2022015333A true MX2022015333A (es) 2023-01-11

Family

ID=80491336

Family Applications (1)

Application Number Title Priority Date Filing Date
MX2022015333A MX2022015333A (es) 2020-09-02 2020-09-02 Medicamento de combinacion para el control y manejo de la diabetes mellitus tipo 2.

Country Status (11)

Country Link
US (1) US20230310462A1 (es)
EP (1) EP4180045A4 (es)
JP (1) JP2023543393A (es)
KR (1) KR20230074742A (es)
BR (1) BR112023003866A2 (es)
CA (1) CA3191302A1 (es)
CO (1) CO2023004272A2 (es)
DO (1) DOP2023000044A (es)
MX (1) MX2022015333A (es)
PE (1) PE20231437A1 (es)
WO (1) WO2022050832A1 (es)

Family Cites Families (7)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
TW200637839A (en) 2005-01-07 2006-11-01 Taisho Pharmaceutical Co Ltd 1-thio-d-glucitol derivatives
US9056134B2 (en) 2010-07-21 2015-06-16 Nucitec S.A. De C.V. Single daily dosage form for prevention and treatment of metabolic syndrome
MX339374B (es) 2011-04-29 2016-05-13 Inst De Investigación En Química Aplic S A De C V Cocristales ionicos con base en metformina.
US20160151382A1 (en) * 2013-10-08 2016-06-02 Kevin Ray Pickering Cooperative Medication Combination Systems
US20170239276A1 (en) * 2014-09-05 2017-08-24 Sanovel Ilac Sanayi Ve Ticaret Anonim Sirketi Pharmaceutical combinations of sitagliptin
KR20180002460A (ko) * 2016-06-29 2018-01-08 주식회사 엘지화학 제2형 당뇨병 및 당뇨성 이상지질혈증 치료용 조성물, 키트 및 병용 요법
AU2020245801A1 (en) * 2019-03-25 2021-11-11 The George Institute for Global Health Low-dose triple combination formulation

Also Published As

Publication number Publication date
KR20230074742A (ko) 2023-05-31
US20230310462A1 (en) 2023-10-05
JP2023543393A (ja) 2023-10-16
CA3191302A1 (en) 2022-03-10
EP4180045A4 (en) 2024-04-10
BR112023003866A2 (pt) 2023-04-04
CO2023004272A2 (es) 2023-06-20
EP4180045A1 (en) 2023-05-17
DOP2023000044A (es) 2023-04-30
PE20231437A1 (es) 2023-09-14
WO2022050832A1 (es) 2022-03-10

Similar Documents

Publication Publication Date Title
YU34404A (sh) N-supstituisani derivati pirolidina kao inhibitori dipeptidil-peptidaze iv
DOP2011000040A (es) Terapia combinada para el tratamiento de la diabetes y afecciones relacionadas y para el tratamiento de afecciones que mejoran mediante un incremento de la concentracion sanguinea de glp-1
BR0314582A (pt) Composições farmacêuticas como inibidoras da dipeptidil peptidase - iv (dpp-iv)
CY1118311T1 (el) Παραγωγα νιτροκατεχολης ως αναστολεις comt που χορηγουνται με ειδικη αγωγη δοσολογιας
NO20090321L (no) Anvendelse av substituerte 2-aminotyetraliner for produksjon av et medikament for forhindringen, lettingen og/eller behandlingen av diverse typer smerte
WO2004037773A8 (en) Phenethanolamine derivative for the treatment of respiratory diseases
WO2008064107A3 (en) 7,8-dihydro-1,6-naphthyridin-5(6h)-ones and related bicyclic compounds as inhibitors of dipeptidyl peptidase iv and methods
DE602006009095D1 (en) Diacylglycerol-acyltransferase-hemmer
AR054383A1 (es) Formulacion de 1-((3- hidroxi-adamant-1- ilamino - acetil) - pirroldin-2-(s) -carbonitrilo de liberacion modificada
ECSP099350A (es) COMPUESTOS DE TETRAHIDROCICLOPENTA[b]INDOL COMO MODULADORES
UA92355C2 (en) urn:schemas-microsoft-com:office:smarttags2,4-DIAMINO-PYRIMIDINES USED AS AURORAINHIBITORS
NO20075973L (no) Dipeptidyl-peptidase-IV-inhibitorer
MY182720A (en) Pharmaceutical compositions
WO2011005811A8 (en) Combination therapy for the treatment of diabetes
NO20083905L (no) Nye pyron-indol derivater og fremgangsmate for deres fremstilling
MX2021015056A (es) Compuesto de pirrolopirimidina y uso del mismo.
MX2021011745A (es) Formulacion de combinacion triple baja en dosis.
NO20063859L (no) Cykloalkylsubstituerte 7-amino-4-kinolon-3-karboksylsyrederivater, fremgangsmate for fremstilling derav og anvendelse derav som medikamenter
MX2022013588A (es) Combinación de fármacos para tratar la diabetes mellitus y sus complicaciones y composición farmacéutica de la combinación de fármacos.
MX2022015333A (es) Medicamento de combinacion para el control y manejo de la diabetes mellitus tipo 2.
BRPI0507030A (pt) combinação de compostos orgánicos
MX2021011746A (es) Formulacion de combinacion triple de dosis baja.
WO2004087880A3 (en) Compounds and their use to treat diabetes and related disorders
WO2019078663A3 (ko) 아연염, 시클로-히스프로 및 항당뇨 약물을 유효성분으로 함유하는 당뇨병 예방 또는 치료용 약학적 조성물
BR112022003183A2 (pt) Usos do inibidor de dpp-iv e de uma combinação do inibidor de dpp-iv e metformina, composição farmacêutica e combinação para retardar perda do controle glicêmico